MANY THANKS TO BLOOMBERG TECHNOLOGY FOR THIS VERY INFORMATIVE ARTICLE
FDA Opens New Path for Alzheimer’s Treatments Anna Edney, Michelle Fay Cortez and Robert Langreth February 15, 2018 9:43 AM Updated on February 15, 2018 1:29 PM · Researchers haven’t settled on cause, target of disease · Draft guidance comes after Merck failure, years of others U.S. drug regulators wants to let drugmakers test Alzheimer’s disease treatments on patients years before the disease shows outward signs, […]